Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(44%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
22%
Ph phase_3
3
33%
Ph phase_4
4
44%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(7)
Completed(2)

Detailed Status

Recruiting3
Not yet recruiting3
Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (33.3%)
Phase 44 (44.4%)
N/A2 (22.2%)

Trials by Status

active_not_recruiting111%
recruiting333%
completed222%
not_yet_recruiting333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9